Page last updated: 2024-10-31

minoxidil and Experimental Neoplasms

minoxidil has been researched along with Experimental Neoplasms in 1 studies

Minoxidil: A potent direct-acting peripheral vasodilator (VASODILATOR AGENTS) that reduces peripheral resistance and produces a fall in BLOOD PRESSURE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p371)
minoxidil : A pyrimidine N-oxide that is pyrimidine-2,4-diamine 3-oxide substituted by a piperidin-1-yl group at position 6.

Research Excerpts

ExcerptRelevanceReference
"The expression of potassium channels in brain tumors is variable, which may be associated with different tumor permeability to therapeutic agents among patients."2.73Different effects of KCa and KATP agonists on brain tumor permeability between syngeneic and allogeneic rat models. ( Bayan, JA; Black, KL; Espinoza, AJ; Hu, J; Irvin, D; Ko, MK; Konda, BM; Ong, JM; Sacapano, MR; Shu, Y; Wang, X; Yin, D, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Black, KL1
Yin, D1
Konda, BM1
Wang, X1
Hu, J1
Ko, MK1
Bayan, JA1
Sacapano, MR1
Espinoza, AJ1
Ong, JM1
Irvin, D1
Shu, Y1

Trials

1 trial available for minoxidil and Experimental Neoplasms

ArticleYear
Different effects of KCa and KATP agonists on brain tumor permeability between syngeneic and allogeneic rat models.
    Brain research, 2008, Aug-28, Volume: 1227

    Topics: Animals; Benzimidazoles; Blood-Brain Barrier; Blotting, Western; Brain Neoplasms; Capillary Permeabi

2008